Fibrocell Science Inc (FCSC)

[scmfinance]

hardly. because there's no way this type of news would boost the share price. all of this research is years out from yielding any sort of revenue. investors have far more immediate concerns. great they're making progress on this front, but i would hope to have a return far in advance of them getting anywhere near making revenue with the stem cell approach.